LNC
58
8
KMB
48
-2
AA
45
2
KMI
77
4
L
62
3
SWK
48
3
TRV
59
7
AKAM
35
3
MAR
33
3
WDC
40
3
NSC
42
3
ALLE
35
-11
CLX
68
2
PPG
45
4
RRC
69
4
BLK
49
3
SYK
42
2
ADSK
43
3
PFG
52
7
BBY
36
3
LNC
58
8
KMB
48
-2
AA
45
2
KMI
77
4
L
62
3
SWK
48
3
TRV
59
7
AKAM
35
3
MAR
33
3
WDC
40
3
NSC
42
3
ALLE
35
-11
CLX
68
2
PPG
45
4
RRC
69
4
BLK
49
3
SYK
42
2
ADSK
43
3
PFG
52
7
BBY
36
3
Financhill
Back

Editas Medicine 10K Form

Sell
13

EDIT
Editas Medicine

Last Price:
$1.41
Seasonality Move:
-10.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDIT News And Ratings

See the #1 stock for the next 7 days that we like better than EDIT

EDIT Financial Statistics

Sales & Book Value

Annual Sales: $32.3M
Cash Flow: $-51.3M
Price / Cash Flow: 0
Annual Sales: $1.62
Price / Book: 0.9

Profitability

EPS (TTM): -2.88000
Net Income (TTM): $-237.1M
Gross Margin: --
Return on Equity: -100%
Return on Assets: -59.47%

Editas Medicine Earnings Forecast

Key Editas Medicine Financial Ratios

  • The Research & Development expenses have been 616.60% of Revenue.
  • The Net Earning history of EDIT is -733.72% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Editas Medicine Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EDIT
CUSIP: 28106W
Website: editasmedicine.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.75
Quick Ratio: 3.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EDIT Technical Analysis vs Fundamental Analysis

Sell
13
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy or a Sell?

  • Editas Medicine stock is rated a Sell
    The current Editas Medicine [EDIT] share price is $1.46. The Score for EDIT is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.